AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30624753 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient powder (MNP) with 10 mg Zn/sachet
Number of subjects: 74
Study 30624753 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient powder (MNP) with 15 mg Zn/sachet
Number of subjects: 74
Study 30624753 — intervention group
Group type: COMPARATOR
Intervention: Comparison with published data on child zinc absorption
Number of subjects: 74
Study 30624753 — intervention group
Group type: EXPERIMENTAL
Intervention: Relation of TAZ to serum α‐1 acid glycoprotein and fecal Entamoeba histolytica
Number of subjects: 74
Study 29343230 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time functional magnetic resonance imaging neurofeedback (3 sessions within 2 weeks)
Number of subjects: 100
Study 29343230 — intervention group
Group type: EXPERIMENTAL
Intervention: Downregulate the ventral striatum
Number of subjects: 100
Study 29343230 — intervention group
Group type: EXPERIMENTAL
Intervention: Upregulate the right inferior frontal gyrus
Number of subjects: 100
Study 29343230 — intervention group
Group type: EXPERIMENTAL
Intervention: Negatively modulate the connectivity between ventral striatum and right inferior frontal gyrus
Number of subjects: 100
Study 29343230 — intervention group
Group type: EXPERIMENTAL
Intervention: Upregulate the auditory cortex
Number of subjects: 100
Study 29343230 — intervention group
Group type: COMPARATOR
Intervention: Downregulate the auditory cortex (control region)
Number of subjects: 100
Study 26728311 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthetic circuit
Number of subjects: 30
Study 26728311 — intervention group
Group type: EXPERIMENTAL
Intervention: Bag-valve-mask (BVM)
Number of subjects: 30
Study 26728311 — intervention group
Group type: EXPERIMENTAL
Intervention: BVM with nasal cannula (NC)
Number of subjects: 30
Study 26728311 — intervention group
Group type: EXPERIMENTAL
Intervention: BVM with positive end-expiratory pressure valve (PEEP)
Number of subjects: 30
Study 26728311 — intervention group
Group type: EXPERIMENTAL
Intervention: BVM + NC + PEEP
Number of subjects: 30
Study 26728311 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrebreather mask (NRM)
Number of subjects: 30
Study 26728311 — intervention group
Group type: EXPERIMENTAL
Intervention: NRM + NC
Number of subjects: 30
Study 24503952 — intervention group
Group type: EXPERIMENTAL
Intervention: Etravirine (ETR) 400 mg/day
Number of subjects: 43
Study 24503952 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued protease inhibitor regimen)
Number of subjects: 43
Study 22824079 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 40 mg/m2 bid for 21 days plus cisplatin 60 mg/m2 (day 8) every 5-week cycle
Number of subjects: 100
Study 22824079 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine 1000 mg/m2 bid for 14 days plus cisplatin 80 mg/m2 (day 1) every 3-week cycle
Number of subjects: 100
Study 19157559 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% brinzolamide 3 times per day
Number of subjects: 26
Study 19157559 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol gel forming solution once every morning
Number of subjects: 26
Study 17998079 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-mode survey design (phone administration followed by mail follow-up for nonresponders)
Number of subjects: 1900
Study 17998079 — intervention group
Group type: EXPERIMENTAL
Intervention: Poststratification weighting adjustments (targeted)
Number of subjects: 1900
Study 14729431 — intervention group
Group type: EXPERIMENTAL
Intervention: Seropositive for IgG antibodies at baseline
Number of subjects: 272
Study 14729431 — intervention group
Group type: EXPERIMENTAL
Intervention: Seropositive for IgA antibodies at baseline
Number of subjects: 272
Study 14729431 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing anti-Chlamydia pneumoniae antibody titers
Number of subjects: 272
Study 14729431 — intervention group
Group type: COMPARATOR
Intervention: Control group (age- and gender-matched patients without coronary events)
Number of subjects: 272
Study 12078851 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide 5%/clindamycin phosphate 1% gel
Number of subjects: 60
Study 12078851 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin phosphate 1% solution
Number of subjects: 60
Study 12078851 — intervention group
Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 60
Study 10825836 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutaraldehyde with zinc oxide eugenol dressing
Number of subjects: 61
Study 10825836 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutaraldehyde with calcium hydroxide dressing
Number of subjects: 61
Study 10825836 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall success rate for glutaraldehyde
Number of subjects: 61
Study 8678260 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced laryngeal mask airway
Number of subjects: 66
Study 8678260 — intervention group
Group type: COMPARATOR
Intervention: Tracheal intubation followed by Guedel airway
Number of subjects: 66
Study 2110388 — intervention group
Group type: COMPARATOR
Intervention: 21% standard amino acids (STD)
Number of subjects: 20
Study 2110388 — intervention group
Group type: EXPERIMENTAL
Intervention: 46% branched-chain amino acids (HBC)
Number of subjects: 20
Study 2110388 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (STD and HBC)
Number of subjects: 20
Study 368965 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% idoxuridine (IDU) dissolved in dimethyl sulphoxide (DMSO)
Number of subjects: 100
Study 368965 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol ointment
Number of subjects: 100
Study 368965 — intervention group
Group type: COMPARATOR
Intervention: Ointment with 60% DMSO
Number of subjects: 100
Study 368965 — intervention group
Group type: COMPARATOR
Intervention: Ointment with 5% IDU and 60% DMSO
Number of subjects: 100
Study 368965 — intervention group
Group type: COMPARATOR
Intervention: Ointment with 40% IDU and 60% DMSO
Number of subjects: 100
Study 31204031 — intervention group
Group type: EXPERIMENTAL
Intervention: McKenzie method
Number of subjects: 70
Study 31204031 — intervention group
Group type: COMPARATOR
Intervention: Motor control exercises
Number of subjects: 70
Study 28710459 — intervention group
Group type: EXPERIMENTAL
Intervention: Genioplasty templates (experimental group)
Number of subjects: 88
Study 28710459 — intervention group
Group type: COMPARATOR
Intervention: Traditional intraoperative measurements (control group)
Number of subjects: 88
Study 25824556 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO4) 5 g in normal saline infused over 6 hours, administered 2 days before surgery, repeated the day before and during surgery.
Number of subjects: 60
Study 25824556 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group).
Number of subjects: 60
Study 23660312 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide posterior release (Group A, n = 15)
Number of subjects: 37
Study 23660312 — intervention group
Group type: COMPARATOR
Intervention: Posterior soft tissue release alone (Group B, n = 22)
Number of subjects: 37
Study 23660312 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide posterior release (Group A, subgroup A1)
Number of subjects: 37
Study 23660312 — intervention group
Group type: COMPARATOR
Intervention: Posterior soft tissue release alone (Group B, subgroup B1)
Number of subjects: 37
Study 23660312 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide posterior release (Group A, subgroup A2)
Number of subjects: 37
Study 23660312 — intervention group
Group type: COMPARATOR
Intervention: Posterior soft tissue release alone (Group B, subgroup B2)
Number of subjects: 37
Study 21410621 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg/day
Number of subjects: 13
Study 21410621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 21410621 — intervention group
Group type: COMPARATOR
Intervention: Normal androgen sensitivity (≥24 CAG repeats)
Number of subjects: 13
Study 19302256 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT)
Number of subjects: 1211
Study 17298712 — intervention group
Group type: EXPERIMENTAL
Intervention: High monounsaturated fat diet (HMF; 50% fat, 20% protein (67 g/d), 30% carbohydrate)
Number of subjects: 0
Study 17298712 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein diet (HP; 40% protein (136 g/d), 30% fat, 30% carbohydrate)
Number of subjects: 0
Study 15145914 — intervention group
Group type: EXPERIMENTAL
Intervention: Older men during isometric contractions
Number of subjects: 18
Study 15145914 — intervention group
Group type: COMPARATOR
Intervention: Young men during isometric contractions
Number of subjects: 18
Study 15145914 — intervention group
Group type: EXPERIMENTAL
Intervention: Older men during dynamic contractions
Number of subjects: 18
Study 15145914 — intervention group
Group type: COMPARATOR
Intervention: Young men during dynamic contractions
Number of subjects: 18
Study 15145914 — intervention group
Group type: EXPERIMENTAL
Intervention: Preexercise half‐time of tetanic torque relaxation in older men
Number of subjects: 18
Study 15105231 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 100 microg plus clonidine 60-150 microg (MC60-150)
Number of subjects: 240
Study 15105231 — intervention group
Group type: COMPARATOR
Intervention: Morphine 100 microg
Number of subjects: 240
Study 15105231 — intervention group
Group type: COMPARATOR
Intervention: Clonidine 150 microg
Number of subjects: 240
Study 15105231 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 100 microg plus clonidine 30 microg
Number of subjects: 240
Study 15105231 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 60-150 microg (combined group)
Number of subjects: 240
Study 9892859 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg, mane)
Number of subjects: 14
Study 9892859 — intervention group
Group type: COMPARATOR
Intervention: Dothiepin (75 mg rising to 150 mg in the second week, nocte)
Number of subjects: 14
Study 7503399 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific serum IgE measurement for egg white
Number of subjects: 21
Study 7503399 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific serum IgE measurement for cow's milk
Number of subjects: 21
Study 7503399 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific serum IgE measurement for egg yolk
Number of subjects: 21
Study 7503399 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxisorp RAST using freshly prepared food extracts
Number of subjects: 21
Study 7503399 — intervention group
Group type: COMPARATOR
Intervention: DBPCFC (double-blind, placebo-controlled food challenge)
Number of subjects: 21
Study 7503399 — intervention group
Group type: COMPARATOR
Intervention: Specific IgE measurements in control subjects tolerant to egg/milk
Number of subjects: 21
Study 1723772 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 40-5967 (200 mg)
Number of subjects: 65
Study 1723772 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 40-5967 (100 mg)
Number of subjects: 65
Study 1723772 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 40-5967 (all doses)
Number of subjects: 65
Study 1723772 — intervention group
Group type: EXPERIMENTAL
Intervention: Ro 40-5967
Number of subjects: 65
Study 1723772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 7178392 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term psychoeducational group intervention, 'Seminars for the Separated'
Number of subjects: 237
Study 7178392 — intervention group
Group type: COMPARATOR
Intervention: Control group (married subjects)
Number of subjects: 237
Study 31774063 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascial Distortion Model (FDM)
Number of subjects: 100
Study 31774063 — intervention group
Group type: COMPARATOR
Intervention: Kaltenborn and Evjenth method
Number of subjects: 100
Study 28369419 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate
Number of subjects: 269
Study 28369419 — intervention group
Group type: COMPARATOR
Intervention: Abacavir
Number of subjects: 269
Study 26133030 — intervention group
Group type: EXPERIMENTAL
Intervention: HPMC (hydroxypropylmethylcellulose)
Number of subjects: 40
Study 26133030 — intervention group
Group type: COMPARATOR
Intervention: Lactose powder (placebo)
Number of subjects: 40
Study 23855333 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 24
Study 23855333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 21273900 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of triamcinolone acetonide
Number of subjects: 99
Study 21273900 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 ml of 1% procaine HCl
Number of subjects: 99
Study 21273900 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of triamcinolone acetonide and 4 ml of 1% procaine HCl
Number of subjects: 99
Study 19255204 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted minimally invasive total knee arthroplasty
Number of subjects: 108
Study 19255204 — intervention group
Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty
Number of subjects: 108
Study 17135285 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (ERT)
Number of subjects: 0
Study 15505867 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary radiation therapy with rhenium-188-DTPA-filled balloon
Number of subjects: 161
Study 11840351 — intervention group
Group type: EXPERIMENTAL
Intervention: Nipradilol
Number of subjects: 7
Study 11840351 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 7
Study 9510277 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Closure (PC)
Number of subjects: 399
Study 9510277 — intervention group
Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene Patch Closure (PTFE-P)
Number of subjects: 399
Study 9510277 — intervention group
Group type: EXPERIMENTAL
Intervention: Vein Patch Closure (VPC)
Number of subjects: 399
Study 7802189 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART needle (Doppler ultrasound guided vascular access device)
Number of subjects: 40
Study 7802189 — intervention group
Group type: COMPARATOR
Intervention: Standard technique (blind, external landmark guided technique)
Number of subjects: 40
Study 29568104 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet
Number of subjects: 583
Study 29568104 — intervention group
Group type: COMPARATOR
Intervention: Low-protein diet
Number of subjects: 583
Study 26523730 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium (Li)
Number of subjects: 225
Study 26523730 — intervention group
Group type: COMPARATOR
Intervention: Valproic acid (VPA)
Number of subjects: 225
Study 26523730 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine (CBZ)
Number of subjects: 225
Study 25102297 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic (US) guidance during PDT (Group A)
Number of subjects: 341
Study 25102297 — intervention group
Group type: COMPARATOR
Intervention: Standard care without image guidance (Group B)
Number of subjects: 341
Study 23514767 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invitation to food supplementation
Number of subjects: 3267
Study 23514767 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal multiple micronutrient supplementation
Number of subjects: 3267
Study 23514767 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher iron supplement
Number of subjects: 3267
Study 20142600 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-emptive treatment (skin moisturizers, sunscreen, topical steroid, doxycycline)
Number of subjects: 95
Study 20142600 — intervention group
Group type: COMPARATOR
Intervention: Reactive treatment (after skin toxicity developed)
Number of subjects: 95
Study 20142600 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-emptive treatment
Number of subjects: 95
Study 20142600 — intervention group
Group type: COMPARATOR
Intervention: Reactive treatment
Number of subjects: 95
Study 19198140 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide
Number of subjects: 0
Study 16573295 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate control
Number of subjects: 4060
Study 16573295 — intervention group
Group type: COMPARATOR
Intervention: Rhythm control
Number of subjects: 4060
Study 16573295 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-free survival
Number of subjects: 4060
Study 14523461 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib
Number of subjects: 55
Study 14523461 — intervention group
Group type: COMPARATOR
Intervention: IFN+AraC
Number of subjects: 55
Study 10739327 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5 to 20 mg/day)
Number of subjects: 1714
Study 10739327 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 1714
Study 9359973 — intervention group
Group type: EXPERIMENTAL
Intervention: human corticotropin-releasing hormone (hCRH)
Number of subjects: 10
Study 9359973 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 10
Study 1470719 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent rest of respiratory muscles through a negative pressure external respirator (shield type) for three consecutive days
Number of subjects: 34
Study 1470719 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group II)
Number of subjects: 34
Study 3548982 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal (500 mg BID, increased to 750 mg BID for non-responders)
Number of subjects: 31
Study 3548982 — intervention group
Group type: COMPARATOR
Intervention: Naproxen (375 mg BID, increased to 500 mg BID for non-responders)
Number of subjects: 31
Study 3548982 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal (safety assessment)
Number of subjects: 31
Study 3548982 — intervention group
Group type: COMPARATOR
Intervention: Naproxen (safety assessment)
Number of subjects: 31
Study 31423703 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 132
Study 31423703 — intervention group
Group type: COMPARATOR
Intervention: Enseal
Number of subjects: 132
Study 29907624 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal douching/enema (RD) performed weekly or more
Number of subjects: 395
Study 29907624 — intervention group
Group type: COMPARATOR
Intervention: Not douching
Number of subjects: 395
Study 27383498 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time tele-transmission system of 12-lead electrocardiogram (Group A)
Number of subjects: 60
Study 27383498 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 60
Study 24356253 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) pediatric tablets (100/25 mg) administered twice daily according to FDA weight bands
Number of subjects: 53
Study 24356253 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/r) pediatric tablets (100/25 mg) administered once daily according to FDA weight bands
Number of subjects: 53
Study 21681387 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adhesive resin cement (RelyX Unicem Aplicap, 3M ESPE)
Number of subjects: 20
Study 21681387 — intervention group
Group type: COMPARATOR
Intervention: Zinc oxide phosphate cement (Hoffmann's Cement, Hoffmann)
Number of subjects: 20
Study 20074698 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal drainage
Number of subjects: 100
Study 20074698 — intervention group
Group type: COMPARATOR
Intervention: External drainage
Number of subjects: 100
Study 18042975 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol
Number of subjects: 69
Study 18042975 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized ipratropium bromide
Number of subjects: 69
Study 18042975 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilator groups (salbutamol and ipratropium)
Number of subjects: 69
Study 18042975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 15653705 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate 30 mg kg(‐1) as a bolus before induction and 10 mg kg(‐1) h(‐1) by infusion
Number of subjects: 60
Study 15653705 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 3 microg kg(‐1) as a bolus before induction and 2 microg kg(‐1) h(‐1) by infusion
Number of subjects: 60
Study 15653705 — intervention group
Group type: COMPARATOR
Intervention: Control group (isotonic solution)
Number of subjects: 60
Study 12375321 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally sensitive cholesterol lowering diet program
Number of subjects: 17
Study 12375321 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 17
Study 10434229 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg chewable tablet of montelukast
Number of subjects: 0
Study 10434229 — intervention group
Group type: COMPARATOR
Intervention: 10 mg film-coated tablet of montelukast (adults)
Number of subjects: 0
Study 7788204 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol inhaled 10 min before induction
Number of subjects: 50
Study 7788204 — intervention group
Group type: COMPARATOR
Intervention: Placebo inhaled 10 min before induction
Number of subjects: 50
Study 2112150 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist (GnRH‐a) leuprolide acetate depot
Number of subjects: 17
Study 2112150 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 17
Study 2112150 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone supplementation in vitro
Number of subjects: 17
Study 2112150 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen in vitro
Number of subjects: 17
Study 2112150 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH‐a in vitro
Number of subjects: 17
Study 472679 — intervention group
Group type: EXPERIMENTAL
Intervention: Björk-Shiley valve
Number of subjects: 35
Study 472679 — intervention group
Group type: COMPARATOR
Intervention: Lillehei-Kaster valve
Number of subjects: 35
Study 31386826 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary advice and HIIT (n = 22)
Number of subjects: 44
Study 31386826 — intervention group
Group type: COMPARATOR
Intervention: Dietary advice only (n = 22)
Number of subjects: 44
Study 30445547 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention to BMI Alone
Number of subjects: 308
Study 30445547 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention to BMI/Medical Risk
Number of subjects: 308
Study 30445547 — intervention group
Group type: COMPARATOR
Intervention: No Attention
Number of subjects: 308